Alimentary Pharmacology & Therapeutics
© John Wiley & Sons Ltd
Edited By: R. E. Pounder and N. J. Talley, J. M. Rhodes, J-F. Colombel, P. C. Hayes, A. C. Ford, C. W. Howden, G. M. Dusheiko, R. Loomba and A. L. Hart
Impact Factor: 5.727
ISI Journal Citation Reports © Ranking: 2014: 9/76 (Gastroenterology & Hepatology); 14/254 (Pharmacology & Pharmacy)
Online ISSN: 1365-2036
FREE: Top Downloads for July and August 2015
Here we present to you a collection of the most frequently downloaded papers in Alimentary Pharmacology & Therapeutics during the months of July and August 2015. Each list is ranked in descending order, with the paper receiving the highest number of downloads in the given month at the top. You may access these papers free of charge by clicking the links below:
Most Accessed August 2015
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon
A. Tursi, A. Papa & S. Danese (Volume 42, Issue 6, Pages 664 – 684).
Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology
L. Lundell et al. (Volume 42, Issue 6, Pages 649 – 663).
Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers
R. Sood et al. (Volume 42, Issue 5, Pages 491 – 503).
Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome
S. S. C. Rao, S. Yu & A. Fedewa (Volume 41, Issue 12, Pages 1256 – 1270).
Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans
L. I. Backus et al. (Volume 42, Issue 5, Pages 559 – 573).
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis
R. Rutgeerts et al. (Volume 42, Issue 5, Pages 504 – 514).
Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
H. Szajewska & M. Kolodziej (Volume 42, Issue 7, Pages 793 – 801).
Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease
S. K. Hourigan et al. (Volume 42, Issue 6, Pages 741 – 752).
Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?
P. Pavlidis et al. (Volume 42, Issue 7, Pages 802 – 817).
Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies
K. Deterding et al. (Volume 42, Issue 7, Pages 889 – 901).
Most Accessed July 2015
Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study
Y. Sakurai et al. (Volume 42, Issue 6, Pages 719 – 730).
Chemotherapy-driven dysbiosis in the intestinal microbiome
E. Montassier et al. (Volume 42, Issue 4, Pages 515 – 528).
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome
B. P. Chumpitazi et al. (Volume 42, Issue 5, Pages 418 – 427).
Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate
M. Fischer et al. (Volume 42, Issue 4, Pages 470 – 467).
Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy
J. P. Gisbert, A. C. Marín & M. Chaparro (Volume 42, Issue 4, Pages 391 – 405).
Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
M-L. Chang, Y-F Liaw & S. J. Hadziyannis (Volume 42, Issue 3, Pages 243 – 257).
Systematic review: colitis associated with anti-CTLA-4 therapy
A. Gupta et al. (Volume 42, Issue 4, Pages 406 – 417).
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
K. Ashida et al. (Volume 42, Issue 6, Pages 685 – 695).
High Helicobacter pylori cure rate with sitafloxacin-based triple therapy
M. Sugimoto et al. (Volume 42, Issue 4, Pages 477 – 483).
Factors governing long-term adherence to a gluten-free diet in adult patients with coeliac disease
J. Villafuerte-Galvez et al. (Volume 42, Issue 6, Pages 753 – 760).